Treatment of high-risk acute lymphoblastic leukemia in adults.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Allogeneic stem cell therapy; Cytarabine; Cytarabine; Daunorubicin; Dexamethasone; Dexamethasone; Fludarabine; Granulocyte colony-stimulating factors; Granulocyte colony-stimulating factors; Hydrocortisone; Idarubicin; Methotrexate; Methotrexate; Pegaspargase; Prednisone; Prednisone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 09 Mar 2020 Biomarkers information updated
- 19 Nov 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 08 Mar 2012 New trial record